Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs. (Q50566566)
Jump to navigation
Jump to search
scientific article published on 21 November 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs. |
scientific article published on 21 November 2008 |
Statements
Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs. (English)
1 reference
Ronald Fried
1 reference
Martine Monnat
1 reference
André Seidenberg
1 reference
Robert Oppliger
1 reference
Patrick Schmid
1 reference
Markus Herold
1 reference
Marc Isler
1 reference
Barbara Broers
1 reference
Christoph Kölliker
1 reference
Peter Schönbucher
1 reference
Markus Frei
1 reference
Milo Huber
1 reference
21 November 2008
1 reference
1 reference
78
1 reference
2-3
1 reference
123-130
1 reference
Identifiers
1 reference